Goldman Sachs Maintains Buy on Aptiv, Lowers Price Target to $71

Benzinga · 1d ago
Goldman Sachs analyst Mark Delaney maintains Aptiv (NYSE:APTV) with a Buy and lowers the price target from $82 to $71.